Tuesday, 7 September 2010

CASE 006 - The pharmaceutical industry

The pharmaceutical industry develops, produces, and markets drugs licensed for use as medications. Pharmaceutical companies can deal in generic and/or brand medications. They are subject to a variety of laws and regulations regarding the patenting, testing and marketing of drugs. The top 7 companies in the world generated in 15 years - around 170 BILLION dollers, all these companies lobbied for either Iraq or Afghanistan. Tamiflu owned by Swiss company Roche headed by Donald rumpfelt, earned around 500 Million dollers in the 1st quarter of year sales in 2009, they are all at the forefront in arms with the UN and WHO to push out and destroy herbal, natural, Traditional medicians. $4.1 trillion is spent globally on health services every year, with $ 750 billion spent in the pharmaceutical market. 10 to 25% of public procurement spending (including on pharmaceuticals) is lost to corrupt practices. In developed countries, fraud and abuse in health care has been estimated to cost individual governments as much as US$ 23 billion per year. Countries with a higher incidence of corruption have higher child mortality rates. Lack of medicines and counterfeit and substandard medicines lead to patient suffering and have direct life or death consequences. To reduce corruption, thorough checks and balances are required at each step in the medicine chain. Good governance includes transparency, accountability, promoting institutional integrity and moral leadership.

Access to health care and essential medicines is needed to reduce disease and death, and enhance quality of life. Medicines are only beneficial when they are safe, of high quality, and properly distributed and used by patients.

The eight deadly lies of Big Pharma

No comments: